structural modifications since its introduction. The purpose of this study was to report the long-term outcomes of a single-center experience of EVAR using the Zenith stent graft.
Prognostic Implications of Diagnosing Frailty and Sarcopenia in Vascular Surgery Practice: Form Versus Function
Amir A. Ghaffarian, Wylie T. Foss, Larry W. Kraiss, Brigitte K. Smith, Claire L. Griffin, Mark R. Sarfati, Benjamin S. Brooke. University of Utah School of Medicine, Salt Lake City, Utah
Objective: Frailty and sarcopenia are related but independent conditions common in older patients that can be used to assess their ability to tolerate the stress of major vascular surgery. However, it is unclear whether frailty or sarcopenia is more predictive of surgical outcomes. We assessed the association of frailty and sarcopenia with long-term survival among patients undergoing surgical and nonsurgical management of vascular disease.
Methods: We retrospectively reviewed all patients who underwent prospective frailty assessment during their vascular surgery clinic visit using the Clinical Frailty Scale between December 2015 and August 2017 and who also underwent an abdominal computed tomography (CT) scan within the preceding 12-month period. The cross-sectional area of skeletal muscle was measured on a single axial CT image at the L3 vertebra. Sarcopenia was defined by established criteria of <52.4 cm 2 /m 2 for men and <38.5 cm 2 /m 2 for women. After patients were stratified by frailty and sarcopenia diagnoses along with comorbidities, the association with all-cause mortality was analyzed using Kaplan-Meier curves and Cox regression models.
Results: A total of 415 patients underwent both frailty and sarcopenia assessment; 112 (27%) met only sarcopenia criteria, 48 (12%) met only frailty criteria, and 56 (13%) were both sarcopenic and frail, whereas 199 (48%) controls did not meet criteria for either condition. A vascular procedure was performed on 167 (40%) patients, whereas 248 (60%) were managed nonoperatively with a median (interquartile range) follow-up after CT imaging of 1.5 (1.1-2.2) years. Patients diagnosed with either sarcopenia or frailty were older (mean, 65 years vs 59 years; p < .01) and more likely to be male (69% vs 54%; P < .01) compared with control patients. Long- e34 Abstracts
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September 2018 term survival was significantly decreased for patients diagnosed with either frailty alone or both frailty and sarcopenia who underwent both surgical (Fig, A) and nonsurgical management (Fig, B) . In multivariate regression models, frailty was the only independent variable (hazard ratio, 7.7; 95% confidence interval, 3.2-18.7; P < .001) that predicted mortality. Conclusions: Although frailty and sarcopenia have both been used to predict long-term survival among vascular patients, our data indicate that frailty alone is the only independent predictor associated with mortality. Objective: Forearm loop grafts are a useful option for dialysis access in patients without suitable forearm veins. Bovine carotid artery (BCA) and expanded polytetrafluoroethylene (ePTFE) grafts are commonly used for this purpose, but no data exist to support the use of one over the other in the forearm loop conformation.
Methods: We performed a retrospective review of 57 forearm loop grafts implanted at two institutions with a shared patient population between January 2009 and May 2017. Primary and secondary patency rates were calculated by univariate analysis and a Cox regression model adjusted for age, sex, and body mass index.
Results: There were 26 BCA and 31 ePTFE grafts placed during the study period. Mean follow-up was 37 6 25 months. Primary and secondary patency rates in the BCA group were 71.7% and 83.6%, 54.8% and 71.1%, and 28.9% and 62.2% at 6, 12, and 24 months, respectively. In the ePTFE group, primary and secondary patency rates were 56. 8% and 66.7%, 39.3% and 59.7%, and 26.9% and 40.4% at 6, 12, and 24 months (Fig) . When adjusted for age, sex, and body mass index, secondary patency was significantly better with BCA compared with ePTFE (P ¼ .04). Infection rates were 7% (two grafts) for BCA and 3% (one graft) for ePTFE.
Conclusions: Bovine carotid xenografts in forearm loop configuration for hemodialysis access have improved secondary patency and similar infection rates compared with ePTFE forearm loops. Author Disclosures: B. Colvard: Nothing to disclose; K. Lavignia: Nothing to disclose; V. T. Ho: Nothing to disclose; N. Itoga: Nothing to disclose; A. Dua: Nothing to disclose; E. J. Harris: Nothing to disclose; M. Mell: Nothing to disclose; E. Sorial: Nothing to disclose; M. Garcia-Toca: Nothing to disclose.
Disease-Based Observation Cohort Study of Patients with Thoracoabdominal Aortic Aneurysm
Chulhi Kang, Matthew A. Bartek, Sherene Shalhub, Derek P. Nathan, Matthew P. Sweet. University of Washington, Seattle, Wash
Objective: Current understanding of thoracoabdominal aortic aneurysms (TAAAs) is limited to case series and administrative data describing patients selected to undergo surgical repair. Little is known about the overall cohort of patients with TAAA, specifically those not selected for repair. The purpose of this study was to describe a disease-based cohort of patients with TAAA.
Methods: An academic multihospital institutional database was screened by diagnosis codes for TAAA from 2009 to 2017 using the International Classification of Diseases, Ninth Revision and Tenth Revision. Diagnosis was then confirmed or rejected by chart review and the CT finding of aneurysmal degeneration >3.2 cm of the paravisceral aorta in continuity with aneurysmal aorta meeting standard criteria for repair. Patients younger than 18 years and those with mycotic aneurysm were excluded. Patients underwent four broad categories of repair: open; endovascular with branched grafts; hybrid, defined as visceral debranching followed by thoracic endovascular aortic repair; and incomplete repair, in which the paravisceral segment was intentionally left unaddressed. The primary outcome measure for those receiving an operation was a composite measure of "good" outcome, defined as survival at 1 year, return to preoperative functional status, and freedom from permanent loss of organ system function.
Results: There were 406 patients who met the inclusion criteria. Demographic data and composite good outcomes are reported in the Table. 
